Complete remission by sorafenib for local reccurence of renal cell carcinoma with a tempraly elevation of C-reactive protein: A case report - Abstract

A 66-year-old man appeared with a local recurrence of RCC 9 months after nephrectomy (clear cell carcinoma > sarcomatoid carcinoma, G2 > 3, pT3a).

A tempraly elevation of serum C-reactive protein (CRP) appeared on administration of sorafenib and decrease of vascularity of the tumor was found on CT. After 13 months of sorafenib administration the recurrent tumor disappeared completely and serum CRP was normalized concomitantly. He currently remains in complete remission for 37 months.

Written by:
Yoshinaga A, Ichiyanagi N, Kamata S.   Are you the author?
Department of Urology, Souka Municipal Hospital.

Reference: Nihon Hinyokika Gakkai Zasshi. 2013 Jul;104(4):609-11.


PubMed Abstract
PMID: 23971370

Article in Japanese.

UroToday.com Renal Cancer Section